Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Motor Activity 22Breast Neoplasms 14Neoplasms 9Fatigue 5Prostatic Neoplasms 4Obesity 4Pancreatic Neoplasms 3Colorectal Neoplasms 3Peripheral Nervous System Diseases 2Overweight 2Neoplasm Metastasis 2Multiple Myeloma 2Lung Neoplasms 2Cognitive Dysfunction 2Cardiovascular Diseases 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Smoking 1Skin Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Osteolysis 1Non-alcoholic Fatty Liver Disease 1Neuroectodermal Tumors, Primitive 1Neurocognitive Disorders 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1

Interventions

Ursodeoxycholic Acid 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Lisinopril 1Exercise 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Non-alcoholic Fatty Liver Disease × Exercise × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡